CAR T-cell therapy involves modifying a patient's T cells to better recognize and attack cancer cells. Here's a detailed breakdown:
What CAR T-Cell Therapy Involves
- Collection: T cells are collected from the patient's blood
- Modification: These T cells are genetically engineered in a lab to produce chimeric antigen Show Full Answer
CAR T-cell therapy involves modifying a patient's T cells to better recognize and attack cancer cells. Here's a detailed breakdown:
What CAR T-Cell Therapy Involves:
- Collection: T cells are collected from the patient's blood.
- Modification: These T cells are genetically engineered in a lab to produce chimeric antigen receptors (CARs) on their surface.
- Multiplication: The modified T cells are multiplied in the lab.
- Infusion: The engineered T cells are infused back into the patient to target and kill cancer cells.
Side Effects:
- Cytokine Release Syndrome (CRS):
- Common symptoms: nausea, fatigue, headache, chills, fever.
- Severe symptoms: low blood pressure, rapid heartbeat, cardiac arrest, kidney issues.
- Severe CRS may require intensive care.
- Neurotoxicity: Potential for neurological side effects.
- Hospital Readmission: Due to the risk of side effects, patients may need to stay close to their treatment center and could be readmitted to manage these effects.
Specific to CLL:
- Remission: Some studies have shown long-term remission in CLL patients, with cases of remission lasting over 10 years.
Caution:
- Relapse: While promising, not all patients achieve remission, and some may relapse.
For more detailed information, you can refer to the articles on MyLeukemiaTeam:
- [Is CAR T-Cell Therapy Possibly a ‘Cure’ for Leukemia?](https://www.myleukemiateam.com/resources/is-car...)
- [BiTE vs. CAR-T Cell Therapy: A Leukemia Treatment Comparison](https://www.myleukemiateam.com/resources/leukem...)
July 12, 2024
Join
Your Privacy Choices
